InflaRx Receives Approval To Initiate Phase IIa Clinical Trial With Lead Candidate IFX-1 In Pyoderma Gangraenosum – Clinical Leader

InflaRx Receives Approval To Initiate Phase IIa Clinical Trial With Lead Candidate IFX-1 In Pyoderma Gangraenosum – Clinical Leader

InflaRx Receives Approval To Initiate Phase IIa Clinical Trial With Lead Candidate IFX-1 In Pyoderma Gangraenosum – Clinical Leader
Published on 2019-02-28